230 related articles for article (PubMed ID: 37056756)
1. Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma.
Zhang K; Yuan E
Front Immunol; 2023; 14():1142126. PubMed ID: 37056756
[TBL] [Abstract][Full Text] [Related]
2. Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework.
Feng Q; Huang Z; Song L; Wang L; Lu H; Wu L
Eur J Med Res; 2023 Aug; 28(1):306. PubMed ID: 37649103
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma.
Yang D; Zhao F; Su Y; Zhou Y; Shen J; Yu B; Zhao K; Ding Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10609-10621. PubMed ID: 37296316
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing.
Song P; Li W; Guo L; Ying J; Gao S; He J
Front Immunol; 2022; 13():850745. PubMed ID: 35757748
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
6. A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma.
Xi D; Wang J; Yang Y; Ji F; Li C; Yan X
BMC Med Genomics; 2023 Sep; 16(1):211. PubMed ID: 37674210
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma.
Guo C; Tang Y; Li Q; Yang Z; Guo Y; Chen C; Zhang Y
Comput Biol Med; 2023 May; 158():106872. PubMed ID: 37030269
[TBL] [Abstract][Full Text] [Related]
8. A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing.
Chen X; Peng C; Chen Y; Ding B; Liu S; Song Y; Li Y; Sun B; Yang R
BMC Bioinformatics; 2023 May; 24(1):216. PubMed ID: 37231356
[TBL] [Abstract][Full Text] [Related]
9. A Novel Prognostic Signature of comprising Nine NK Cell signatures Based on Both Bulk RNA Sequencing and Single-Cell RNA Sequencing for Hepatocellular Carcinoma.
Yu Q; Shi X; Wang H; Zhang S; Hu S; Cai T
J Cancer; 2023; 14(12):2209-2223. PubMed ID: 37576389
[No Abstract] [Full Text] [Related]
10. NK cell marker gene-based model shows good predictive ability in prognosis and response to immunotherapies in hepatocellular carcinoma.
Li J; Li Y; Li F; Xu L
Sci Rep; 2023 May; 13(1):7294. PubMed ID: 37147523
[TBL] [Abstract][Full Text] [Related]
11. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
[TBL] [Abstract][Full Text] [Related]
12. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
13. Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma.
Ye J; Tian W; Zheng B; Zeng T
Medicine (Baltimore); 2023 Nov; 102(45):e35938. PubMed ID: 37960718
[TBL] [Abstract][Full Text] [Related]
14. A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma.
Xiao J; Liu T; Liu Z; Xiao C; Du J; Zuo S; Li H; Gu H
Cells; 2022 Jul; 11(15):. PubMed ID: 35892599
[TBL] [Abstract][Full Text] [Related]
15. Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.
Liu H; Zhao R; Qin R; Sun H; Huang Q; Liu L; Tian Z; Nashan B; Sun C; Sun R
Cancer Biol Med; 2022 Jul; 19(9):1334-51. PubMed ID: 35856557
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Gao B; Wang Y; Li C; Lu S
Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
[TBL] [Abstract][Full Text] [Related]
18. A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma.
Zhang T; Gu J; Wang X; Lu Y; Cai K; Li H; Nie Y; Chen X; Wang J
Front Immunol; 2023; 14():1140201. PubMed ID: 36936935
[TBL] [Abstract][Full Text] [Related]
19. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]